Company profile for First Wave BioPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and an...
First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
777 Yamato Road Suite 502 Boca Raton, FL 33431
Telephone
Telephone
(561) 589-7020
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/entero-exits-laying-staff-vacating-office-and-pausing-rd-mattress-provides-hard-landing

FIERCE BIOTECH
08 Aug 2024

https://www.contractpharma.com/contents/view_breaking-news/2024-05-16/first-wave-biopharma-rebrands-to-entero-therapeutics/

CONTRACT PHARMA
16 May 2024

https://www.globenewswire.com/news-release/2024/05/16/2883267/0/en/First-Wave-BioPharma-Changes-Name-to-Entero-Therapeutics.html

GLOBENEWSWIRE
16 May 2024

https://www.globenewswire.com/news-release/2024/05/10/2879566/0/en/First-Wave-BioPharma-Inc-to-raise-approximately-1-1-million-of-Gross-Proceeds-Priced-At-the-Market.html

GLOBENEWSWIRE
10 May 2024

https://www.globenewswire.com/news-release/2024/05/09/2878593/0/en/First-Wave-BioPharma-and-Celiac-Journey-to-Host-Nasdaq-Event-in-Support-of-Celiac-Disease-Awareness-Month.html

GLOBENEWSWIRE
09 May 2024

https://www.globenewswire.com/news-release/2024/04/24/2868451/0/en/First-Wave-BioPharma-Announces-Invited-Paper-for-Special-Edition-on-Celiac-Disease-in-Peer-Reviewed-Scientific-Journal-Nutrients.html

GLOBENEWSWIRE
24 Apr 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty